12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Company News  |  Deals

AstraZeneca, Cornell University, Feinstein Institute, University of British Columbia, Washington University deal

AstraZeneca and four academic laboratories formed a drug discovery partnership focused on apolipoprotein E (APOE) epsilon 4 in Alzheimer's disease. The A5 alliance includes Steven Paul at the Helen...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >